Rare or orphan diseases encompass nearly 7,000 known indications, and most do not have treatments or known causes.

Signant is a steadfast partner and advocate of research and development efforts to identify new therapies for orphan diseases. Our on-staff experts partner with research teams to faciliate the clinical development process, focusing on these areas:

• Endpoint data accuracy and reliability
• Participant and site experience
• Optimized global operations

Learn specifically how we pair our clinical research solutions such as eCOA and Blinded Data Analytics with scientific expertise to improve orphan disease research outcomes.